D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET

International Journal of Neuropsychopharmacology

Volumn 13, Issue 3, 2010, Pages 291-292

  Day, Mark ^a   Bain, Earle ^a   Marek, Gerard ^a   Saltarelli, Mario ^a   Fox, Gerard B ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 925; CARBON 11; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; NAXAGOLIDE; NAXAGOLIDE C 11; OLANZAPINE; PRAMIPEXOLE; RADIOLIGAND; RISPERIDONE; UNCLASSIFIED DRUG; OXAZINE DERIVATIVE;

CENTRAL NERVOUS SYSTEM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; GLOBUS PALLIDUS; HUMAN; LETTER; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; ARTICLE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; METHODOLOGY; SCINTISCANNING;

BRAIN; HUMANS; OXAZINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D3;

EID: 77953535369     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000180     Document Type: Letter

References (10)

1. Freedman SB, Patel S, Marwood R, Emms F, et al. (1994). Expression and pharmacological characterization of the human D3 dopamine receptor. Journal of Pharmacology and Experimental Therapeutics 268, 417-426.
2. 11C]-(+)- PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. Journal of Neurochemistry 97, 1089-1103.
3. 11C]-(+)-PHNO PET study. Neuropsychopharmacology 34, 1078-1086.
4. 3 receptor antagonist ABT-925. International Journal of Neuropsychopharmacology. Published online: 15 September 2009. doi:10.1017/S1461145709990642.
5. 11C]raclopride in healthy humans. Human Brain Mapping 29, 400-410.
6. 11C]fallypride. Synapse 63, 447-461.
7. 11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse 60, 485-495.
8. 11C](+)-PHNO positron emission tomography (PET). International Journal of Neuropsychopharmacology. Published online: 11 February 2010. doi:10.1017/S1461145710000088.
9. Rabiner EA, Slifstein M, Nobrega J, Plisson C, et al. (2009). In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice. Synapse 63, 782-793.
10. 11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology 33, 279-289.